[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:disease":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,51,78,106,131,154],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":34,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100536954","phase-4-evaluation-of-efficacy-of-skl-pro-powder-on-symptoms-of-irritable-bowel-syndrome-100536954",false,"NCT06271538","Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome","A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)","Inclusion Criteria:\n\n* IBS diagnosed using the Rome IV criteria\n* Age above 18 years old and any gender\n* Any subtypes of IBS (diarrhea, constipation or mixed)\n\nExclusion Criteria:\n\n* Presence of red flag symptoms (weight loss, anemia, night symptoms, abdominal mass, strong family history of cancer)\n* Was prescribed antibiotic (s) within the past one month\n* Medical conditions that contraindicate probiotic use including severe sepsis and pregnancy\n* Presence of bowel malignancy\n* Diagnosis of bowel infection within the past one month\n* Previous abdominal surgeries\n* Patients with overt psychiatric illnesses including schizophrenia and manic disorders\n* A history of allergy to probiotic\n* Was prescribed probiotic (s) within the past one month\n* Was previously prescribed probiotic Skal Pro™ (LP299V™)","ALL","18 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.",[26,27,28,29,30,31,32,33],"Irritable Bowel Syndrome","Gastrointestinal Diseases","Colonic Diseases, Functional","Intestinal Disease","Digestive System Disease","Pathologic Processes","Colonic Disease","Disease",[35,36,37],"probiotic","Lactobacillus plantarum 299v","randomized controlled study","RECRUITING","2026-05-11",{"date":41,"type":42},"2026-05-12","ACTUAL",{"date":44,"type":42},"2024-10-17",{"date":46,"type":20},"2026-06-30",{"name":48,"class":49},"EP Plus Group Sdn Bhd","INDUSTRY",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":4},"100581993","the-relationship-of-hand-sensory-and-strength-assessments-with-functionality-and-kinesiophobia-in-individuals-with-rheumatoid-arthritis-100581993","NCT06857526","The Relationship of Hand Sensory and Strength Assessments with Functionality and Kinesiophobia in Individuals with Rheumatoid Arthritis","Inclusion Criteria:\n\n* Female patients between 18-65 years of age\n* Patients whose medical treatment has been stable for the last 3 months\n\nExclusion Criteria:\n\n* Patients who have undergone surgery on the hand and wrist\n* Patients with prosthesis\n* Patients with neurological or orthopedic diseases\n* Patients with another accompanying rheumatic disease\n* Patients with malignancy\n* Pregnant patients","65 Years",{"count":59,"type":20},50,"OBSERVATIONAL","Rheumatoid arthritis (RA) is a systemic inflammatory disease that can involve all tissues with synovium. The wrist and hand, which are of great importance in our daily activities, are involved early and specifically because they are rich in synovium, which is the target tissue in RA.In many patients with rheumatoid arthritis, hand and wrist involvement is seen from the early stages of the disease. Pain, stiffness and swelling in the joint are accompanied by decreased range of motion and muscle strength.Hand functions have a very important place due to the fact that the hand must be used in countless daily life activities.Kinesiophobia is defined as a state of fear and avoidance of activity and physical movement caused by painful injury and sensitivity to repeated injury.The aim of this study was to investigate the relationship between hand sensory and strength assessment, functionality and kinesiophobia in individuals with rheumatoid arthritis.",[33],[64,65,66],"hand force assessment","hand sensory evaluation","romatoid artrit","NOT_YET_RECRUITING","2025-02-26",{"date":70,"type":42},"2025-03-04",{"date":72,"type":20},"2025-03-05",{"date":74,"type":20},"2025-06-05",{"name":76,"class":77},"Firat University","OTHER",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":85,"targetDuration":87,"studyType":60,"phases":4,"briefSummary":88,"conditions":89,"keywords":94,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":50},"100579570","trectamu-cancer-prevention-registry-and-repository-100579570","NCT06826014","TREC@TAMU Cancer Prevention Registry and Repository","Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository","Inclusion Criteria:\n\n* 18 years of age and older, and,\n* People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and,\n* People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and,\n* Able to give and comprehend the consent process, and,\n* Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and,\n* Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and,\n* All sexes and gender identities.\n\nExclusion Criteria:\n\n* Declines to participate or interact with staff\u002Fshare their medical status.\n* A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded",{"count":86,"type":20},2500,"5 Years","This study collects health and genetic information to implement cancer prevention and treatment strategies.",[90,91,33,92,93],"Cancer","Genetics","Diet","Lifestyle Factors",[95,96],"cancer","genetics","2025-02-11",{"date":99,"type":42},"2025-02-13",{"date":101,"type":20},"2025-03",{"date":103,"type":20},"2030-11",{"name":105,"class":77},"Texas A&M University",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":113,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":114,"targetDuration":116,"studyType":60,"phases":4,"briefSummary":117,"conditions":118,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":50},"100578499","human-microbiome-research-and-development-for-overcoming-pediatric-diseases-100578499","NCT06812091","Human Microbiome Research and Development for Overcoming Pediatric Diseases","Prediction and Treatment of Pediatric Diseases and Long-term Outcomes Through Microbiome and Multi-Omics Study by Life Cycle","Inclusion Criteria:\n\n* children (including newborns) who have obtained their consent from their guardians\n\nExclusion Criteria:\n\n* subjects who did not obtain consent",true,{"count":115,"type":20},500,"10 Years","Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.",[119,120,33,121],"Human Microbiome","Pediatrics","Growth & Development","2025-02-01",{"date":124,"type":42},"2025-02-06",{"date":126,"type":42},"2022-01-01",{"date":128,"type":20},"2030-01-01",{"name":130,"class":77},"Hanyang University",{"id":132,"slug":133,"hasResults":11,"nctId":134,"briefTitle":135,"officialTitle":135,"acronym":4,"eligibilityCriteria":136,"healthyVolunteers":113,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":137,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":139,"conditions":140,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":50},"100522348","public-survey-on-breath-testing-for-health-and-disease-100522348","NCT06081452","Public Survey on Breath Testing for Health and Disease","Inclusion Criteria:\n\n* Member of the public above the age of 18\n\nExclusion Criteria:\n\n* Member of the public below the age of 18",{"count":138,"type":20},1000,"A brief survey for the public to determine interest in health surveillance and disease detection",[90,33,141,142,143,144],"Health Behavior","Health Attitude","Health-Related Behavior","Health Knowledge, Attitudes, Practice","2025-01-27",{"date":147,"type":42},"2025-01-28",{"date":149,"type":42},"2023-06-17",{"date":151,"type":20},"2025-10-17",{"name":153,"class":77},"Imperial College London",{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":159,"acronym":160,"eligibilityCriteria":161,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":162,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":164,"conditions":165,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":170,"lastUpdatePostDateStruct":171,"startDateStruct":173,"completionDateStruct":175,"leadSponsor":177,"locationsCount":50},"100564346","multi-disciplinary-treatment-on-the-anthropomorphism-of-large-language-models-100564346","NCT06627985","Multi-Disciplinary Treatment on the Anthropomorphism of Large Language Models","Multi-Disciplinary Treatment on the Anthropomorphism of Large Language Models: A Parallel Controlled Study","MDTALLM","Inclusion Criteria:\n\n* 1\\. The medical records include interdisciplinary consultation notes, with recommendations from specialists of various departments and a well-documented final summary.\n* 2\\. The medical records contain data from at least one year prior to and one year following the consultation (including intact reports and imaging records).\n* 3\\. The patient\\'s discharge conditions improved due to the multidisciplinary treatment plan after the consultation.\n\nExclusion Criteria:\n\n* 1\\. The medical records do not include multidisciplinary consultation notes, or the recommendations from various departmental physicians and the final summary notes are incomplete or inadequate.\n* 2\\. The medical records lack data from 1 year before and after the consultation, or miss necessary reports and imaging data, resulting in incomplete documentation.\n* 3\\. The patient\\'s condition at discharge has not improved following the multidisciplinary treatment plan, or the condition has worsened.",{"count":163,"type":20},300,"This retrospective clinical trial aims to better explore the potential of large language models in medicine by comparing the effectiveness of MDT consultations conducted by human doctors with those conducted by large language models.\n\nThe main questions to be addressed are:\n\nDoes using large language models to conduct anthropomorphic MDT consultations yield better results than using non-anthropomorphic processes? Is there a significant performance gap between MDT consultations conducted by large language models and those conducted by humans? How much greater is the economic benefit of MDT consultations from large language models compared to those conducted by humans?\n\nRetrospectively collect MDT consultation records from the past 20 years in northern Sichuan in China, as well as anonymized patient medical records. Group 1: Different large language models are assigned to act as doctors from different departments and as MDT secretaries to summarize consultations. Group 2: The large language model directly outputs diagnostic and treatment recommendations for patients. Compare the outputs of groups 1 and 2 with human performance retrospectively, score them, and select the best model from each department for a re-evaluation through anthropomorphic MDT consultations, once again comparing them to human results.",[90,166,167,168,169,33],"Respiratory Failure","Heart Diseases","Infections","Pneumonia","2024-10-03",{"date":172,"type":42},"2024-10-04",{"date":174,"type":20},"2024-10-01",{"date":176,"type":20},"2024-11-01",{"name":178,"class":77},"North Sichuan Medical College"]